LSM4 antibody
Product Specifications
Background
This gene encodes a member of the LSm family of RNA-binding proteins. LSm proteins form stable heteromers that bind specifically to the 3'-terminal oligo (U) tract of U6 snRNA and may play a role in pre-mRNA splicing by mediating U4/U6 snRNP formation. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene.
Synonyms
U6 snRNA-associated Sm-like protein LSm4|Glycine-rich protein (GRP) |LSM4
Gene ID
25804
UniProt
Q9Y4Z0
Host
Rabbit
Reactivity
Human, Mouse, Rat
Immunogen
LSM4 homolog, U6 small nuclear RNA associated
Target
LSM4
Clonality
Polyclonal
Isotype
IgG
Applications
ELISA, WB, IHC, IP
Field of Research
Epigenetics, Metabolism
Purification
Immunogen affinity purified
Dilution
WB: 1:500 - 1:2000; IHC: 1:50 - 1:200; IP: 1:50 - 1:200
Purity
≥95% as determined by SDS-PAGE
Form
Liquid
Molecular Weight
15 kDa
Shipping Conditions
4°C with ice bag
Storage Conditions
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20°C for 12 months (Avoid repeated freeze / thaw cycles.)
Tested Applications
ELISA, WB, IHC, IP
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
A00410-5-Biotin 100 µg/Vial
Anti-DR5/TNFRSF10B Antibody Picoband® (Biotine Conjugate)
Ask
View Details 
MBS4380676-01 0.02 mg (With BSA & Azide at 0.2mg/mL)
RAD51 (Prognostic and Response to Chemotherapy Marker)
Ask
View Details 
MBS4380676-02 0.1 mg (With BSA & Azide at 0.2mg/mL)
RAD51 (Prognostic and Response to Chemotherapy Marker)
Ask
View Details MBS4380676-03 0.1 mg (Without BSA & Azide at 1mg/mL)
RAD51 (Prognostic and Response to Chemotherapy Marker)
Ask
View Details MBS4380676-04 5x 0.1 mg (With BSA & Azide at 0.2mg/mL)
RAD51 (Prognostic and Response to Chemotherapy Marker)
Ask
View Details MBS4380676-05 5x 0.1 mg (Without BSA & Azide at 1mg/mL)
RAD51 (Prognostic and Response to Chemotherapy Marker)
Ask
View Details